Theolytics Limited
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients (NCT07211659) | Theolytics Limited | 2026-02-13 |
| Trial of THEO-260 in Ovarian Cancer Patients (NCT06618235) | Theolytics Limited | 2024-09-24 |
Track Theolytics Limited automatically
Every clearance here is in the API, with alerts when new ones post.